Differential Antiatherogenic Effects of PPAR Versus PPAR Agonists: Should We Be Surprised?
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000181034.54148.8d
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2005
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)